MENU
NRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NeuroSense Therapeutics (NRSN) Earnings Date & Reports

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

A.I. Advisor
published Earnings

NRSN is expected to report earnings to fall 55.05% to -6 cents per share on November 26

NeuroSense Therapeutics NRSN Stock Earnings Reports
Q3'25
Est.
$-0.06
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.04
Q4'24
Missed
by $0.46
Q3'24
Beat
by $0.03
The last earnings report on August 01 showed earnings per share of -13 cents, beating the estimate of -22 cents. With 169.62K shares outstanding, the current market capitalization sits at 29.28M.
View a ticker or compare two or three
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRSN showed earnings on August 01, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
14
Web
https://www.neurosense-tx.com